Search
for

    Sort by

    Research

    300-330 / 1000+ results
      Atlas of Geriatric Dermatology

      research Atlas of Geriatric Dermatology

      2 citations, January 2014 in “Springer eBooks”
      The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.
      Dialogues in Dermatology: Highlights from 2011

      research Dialogues in Dermatology: Highlights from 2011

      January 2012 in “Journal of the American Academy of Dermatology”
      2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.
      Reporting on Adverse Clinical Events

      research Reporting on Adverse Clinical Events

      March 2021 in “Clin-Alert”
      The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.
      Highlights

      research Highlights

      July 2019 in “Journal of the Formosan Medical Association”
      Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.
      Telogen Effluvium: Causes, Diagnosis, and Treatment

      research Telogen Effluvium: Causes, Diagnosis, and Treatment

      144 citations, July 2002 in “Clinical and Experimental Dermatology”
      Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.
      Endocrine and Reproductive Effects of Polycystic Ovarian Syndrome

      research Endocrine and Reproductive Effects of Polycystic Ovarian Syndrome

      18 citations, December 2014 in “Obstetrics and Gynecology Clinics of North America”
      Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.
      Skin Diseases Due to Endocrine Alterations

      research Skin Diseases Due to Endocrine Alterations

      16 citations, January 2006 in “The Aging Male”
      Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.
      Table 1

      research Table 1

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.
      Table 2

      research Table 2

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.
      Gonads

      research Gonads

      November 2013 in “John Wiley & Sons, Ltd eBooks”
      The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.
      Alopecia

      research Alopecia

      January 2007 in “Elsevier eBooks”
      Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.
      GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

      research GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

      59 citations, August 2021 in “Frontiers in Endocrinology”
      GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.